AI assistant
Sending…
Mirum Pharmaceuticals, Inc. — Director's Dealing 2021
May 12, 2021
31228_dirs_2021-05-12_804ee35d-1c9c-4835-bbfd-fcf92f20644e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-05-10
Reporting Person: Tucker Edwin Jonathan (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-10 | Common Stock | A | 1483 | $14.62 | Acquired | 39007 | Direct |
Footnotes
F1: This Form 4 is being filed voluntarily to report the acquisition of 1,483 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan.
More from Mirum Pharmaceuticals, Inc.
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Annual Report
2026
Apr 24
M&A Activity
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18